EUVIMEDEUVIMED entdecken
Crossref

Management of retinoblastoma during the Covid-19 pandemic: Experience at a tertiary care centre

Yogita Gupta, Neiwete Lomi, Nimmy Raj, Alisha Kishore, Radhika Tandon

The National Medical Journal of India · 25.03.2026 · 39 · 150-153

DOI: 10.25259/nmji_558_2023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The National Medical Journal of India, online erschienen am 25.03.2026. Verfasst von Yogita Gupta und 4 weiteren Autor:innen. Beteiligte Einrichtung: Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India. Hauptthemen laut MEDLINE: Retinoblastoma, COVID-19, Retinal Neoplasms. Die Arbeit nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Covid-19 disease and the imposed lockdown adversely affected patient care at healthcare facilities worldwide. Children affected with retinoblastoma require uninterrupted care due to systemic immunosuppression and the chances of disease relapse. We evaluated the impact of Covid-19 on patients with retinoblastoma and report a strategy to mitigate this impact.

Methods

We reviewed records of patients attending the ophthalmic emergency from March 2020 to March 2021. Patients with retinoblastoma were categorized based on their urgency level, and managed as per the treatment protocol. The relevant demographic data, clinical profile, referral details, and management strategy used were recorded and analysed.

Results

Fifty patients with retinoblastoma were reviewed (males 31 [62%], mean age 3.33 years). After Covid-19 screening, an ophthalmic examination was done, and an ocular diagnosis was established. The categorization was: 1 emergent, 21 urgent, 26 semi-urgent, and 2 non-urgent patients. Of the 47 patients tested for Covid-19, two were positive and the intervention was deferred. An intervention was delivered in 41 patients (1 orbital biopsy, 9 enucleation, 27 focal therapy, 4 systemic chemotherapy), and 9 received no intervention. A 78.7% reduction in new patients was seen in attendance of the retinoblastoma clinic (p=0.02). All healthcare professionals used personal protective equipment. Teleconsultations were encouraged wherever possible. Support of non-governmental organizations was sought for patient mobilization.

Conclusion

The described model exemplifies a strategy to mitigate the impact of Covid-19 and lockdown on healthcare delivery to patients with retinoblastoma for a year.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RetinoblastomaCOVID-19Retinal NeoplasmsHumansTertiary Care CentersFemaleMaleChild, PreschoolInfantIndiaSARS-CoV-2Retrospective StudiesChild

Autor:innen und Institutionen

  • Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.

Zitieren

APA

Gupta, Y., Lomi, N., Raj, N., Kishore, A., & Tandon, R. (2026). Management of retinoblastoma during the Covid-19 pandemic: Experience at a tertiary care centre. The National Medical Journal of India, 39, 150-153. https://doi.org/10.25259/nmji_558_2023

Vancouver

Gupta Y, Lomi N, Raj N, Kishore A, Tandon R. Management of retinoblastoma during the Covid-19 pandemic: Experience at a tertiary care centre. The National Medical Journal of India. 2026;39:150-153. doi:10.25259/nmji_558_2023

BibTeX
@article{Gupta2026,
  author = {Gupta, Yogita and Lomi, Neiwete and Raj, Nimmy and Kishore, Alisha and Tandon, Radhika},
  title = {Management of retinoblastoma during the Covid-19 pandemic: Experience at a tertiary care centre},
  journal = {The National Medical Journal of India},
  year = {2026},
  volume = {39},
  pages = {150--153},
  doi = {10.25259/nmji_558_2023}
}
Kostenlos starten →